Skip to content

High-flow nasal humidified oxygen therapy in patients having anesthesia for gastroscopy at high altitude

High-flow nasal humidified oxygen therapy in patients having anesthesia for gastroscopy at high altitude: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045513
Enrollment
Unknown
Registered
2021-04-18
Start date
2021-04-30
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoxemia

Interventions

Experimental group:High flow nasal humidified oxygen therapy
Control group:Traditional nasal cannula oxygen therapy

Sponsors

People's Hospital of the Tibet Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients (18 years of age and older) who underwent elective anesthesia gastroscopy performed for 15 minutes or more.

Exclusion criteria

Exclusion criteria: Patients with high risk of reflux aspiration (emergency, pregnant women, gastroesophageal reflux, etc.), facial or upper respiratory tract trauma can not wear, severe nasal obstruction.

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia;

Secondary

MeasureTime frame
Incidence of hypercarbia;Incidence of hypotension;

Countries

China

Contacts

Public ContactQuan Xiang

Peking Union Medical College Hospital, People's Hospital of the Tibet Autonomous Region

quan79102@188.com+86 13683658102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026